Dermalux FlexMD, Руководство пользователя

Страница: 6 / 25

Aesthetic Technology Limited
10 11
PL-027 (Rev 7) PL-027 (Rev 7)
LED Phototherapy is well evidenced for its regenerative and anti-inflammatory benefits
without creating trauma, making it safe and suitable for all skin types. Due to the
non-invasive nature and high safety profile of the treatment, the scope for use extends
across a wide range of applications.
The Dermalux® Flex MD system delivers three clinically proven wavelengths via 7
treatment options selected through the Controller. These wavelengths are 415nm,
633nm and 830nm.
• Skin Rejuvenation
• Complexion
• Dry Skin
• Pigmentation: Photo-damage
• Pigmentation
• Acne: Mild to Moderate
• Acne: Moderate to Severe
• Redness: Vascular
• Redness: Skin Tone
• Sensitive Skin
• Sensitive Skin: Problem conditions
• Psoriasis
• Wound Healing
• Pain
Refer to Flex MD Treatment Protocol manual (PL-038) for a detailed explanation
of protocols.
Indications for use include but are not limited to the following:
The Dermalux® LED Phototherapy treatment is safe and well tolerated, however
there are certain circumstances and medical conditions in which treatment may
prove to be unsuitable.
Prior to treatment, we strongly recommend that all clients complete and sign the
Dermalux® Consent Form (PL-012, available at learn.dermaluxled.com) and disclose
any medications or medical conditions which may contraindicate the treatment at
the current time (available in our online materials). Failure to do so may increase
the risk of an unwanted or adverse reaction. For more information about Adverse
Reactions please refer to Section 14.